Itron, Inc. (NASDAQ:ITRI) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Itron, Inc. (NASDAQ:ITRI) have received a consensus rating of “Moderate Buy” from the eleven research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $137.10.

ITRI has been the subject of a number of analyst reports. Wall Street Zen upgraded Itron from a “hold” rating to a “buy” rating in a research note on Friday. Stephens set a $130.00 price target on Itron in a research note on Monday, August 4th. Guggenheim reissued a “buy” rating and set a $155.00 target price (up previously from $133.00) on shares of Itron in a research report on Monday, July 14th. Roth Capital lifted their target price on shares of Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Itron in a research report on Saturday, September 27th.

Itron Price Performance

ITRI stock opened at $125.44 on Friday. The company has a market capitalization of $5.73 billion, a P/E ratio of 21.44, a price-to-earnings-growth ratio of 0.68 and a beta of 1.48. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. Itron has a 52-week low of $90.11 and a 52-week high of $140.04. The business has a 50-day simple moving average of $124.03 and a two-hundred day simple moving average of $119.14.

Itron (NASDAQ:ITRI) last released its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.29. The business had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Research analysts expect that Itron will post 5.33 EPS for the current fiscal year.

Insider Activity

In other Itron news, CFO Joan S. Hooper sold 970 shares of Itron stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $121,550.70. Following the transaction, the chief financial officer owned 88,394 shares of the company’s stock, valued at $11,076,652.14. This trade represents a 1.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Christopher E. Ware sold 351 shares of Itron stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $43,983.81. Following the transaction, the senior vice president directly owned 19,117 shares in the company, valued at approximately $2,395,551.27. This represents a 1.80% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 3,037 shares of company stock worth $380,566. Corporate insiders own 1.45% of the company’s stock.

Hedge Funds Weigh In On Itron

Several institutional investors have recently bought and sold shares of the company. EverSource Wealth Advisors LLC raised its holdings in shares of Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after buying an additional 81 shares during the last quarter. Louisiana State Employees Retirement System raised its holdings in shares of Itron by 0.5% in the second quarter. Louisiana State Employees Retirement System now owns 21,300 shares of the scientific and technical instruments company’s stock worth $2,804,000 after buying an additional 100 shares during the last quarter. Amalgamated Bank raised its holdings in shares of Itron by 0.9% in the second quarter. Amalgamated Bank now owns 12,974 shares of the scientific and technical instruments company’s stock worth $1,708,000 after buying an additional 115 shares during the last quarter. Elevation Point Wealth Partners LLC raised its holdings in shares of Itron by 3.5% in the second quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock worth $447,000 after buying an additional 115 shares during the last quarter. Finally, J.W. Cole Advisors Inc. raised its holdings in shares of Itron by 6.0% in the second quarter. J.W. Cole Advisors Inc. now owns 2,056 shares of the scientific and technical instruments company’s stock worth $271,000 after buying an additional 116 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.